Home › Islet Cell Adenoma › Ohio › Columbus
Islet Cell Adenoma clinical trials in Columbus, OH
4 studies for Islet Cell Adenoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Columbus
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Columbus
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Islet Cell Adenoma trials in other cities
- Rochester, MN5 studies
- Los Angeles, CA5 studies
- St. Louis, MO5 studies
- Phoenix, AZ4 studies
- Washington, DC4 studies
- Salt Lake City, UT4 studies
- Portland, OR4 studies
- Lexington, KY4 studies
- Chicago, IL4 studies
- Jacksonville, FL3 studies
- Irvine, CA3 studies
- Philadelphia, PA3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.